BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6977367)

  • 1. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
    Wedelin C; Björkholm M; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Br J Cancer; 1982 Jan; 45(1):70-9. PubMed ID: 6977367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up.
    Tullgren O; Grimfors G; Holm G; Johansson B; Svedmyr E; Wedelin C; Mellstedt H; Merk K; Björkholm M
    Cancer; 1991 Aug; 68(4):768-75. PubMed ID: 1855177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
    van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
    Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease.
    Björkholm M; Askergren J; Wedelin C; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jul; 25(1):51-7. PubMed ID: 6969422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
    Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease.
    Björkholm M; Wedelin C; Holm G; Johansson B; Mellstedt H
    Cancer; 1981 Nov; 48(9):2010-5. PubMed ID: 7296509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
    Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
    Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological defects in healthy twin siblings to patients with Hodgkin's disease.
    Björkholm M; Holm G; De Faire U; Mellsted H
    Scand J Haematol; 1977 Oct; 19(4):396-404. PubMed ID: 562530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic profile of patients with cured Hodgkin's disease.
    Bjorkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease.
    Björkholm M; Wedelin C; Holm G; Ericsson H; Nilsson P; Mellstedt H
    Cancer; 1982 Nov; 50(10):2044-8. PubMed ID: 7127249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency and prognosis in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H; Johansson B
    Acta Med Scand; 1975 Oct; 198(4):275-9. PubMed ID: 1081328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphocyte response in Hodgkin's disease.
    Braeman J; Evans IH; Deeley TJ
    Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunodeficiency and prognosis in patients with non-Hodgkin's lymphomas.
    Lindemalm C; Biberfeld P; Björkholm M; Holm G; Johansson B; Mellstedt H; Nilsson B; Ost A
    Acta Radiol Oncol; 1985; 24(2):159-65. PubMed ID: 2988279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal studies of blood lymphocyte functions in non-Hodgkin's lymphoma.
    Simonsson-Lindemalm C; Biberfeld P; Björkholm M; Holm G; Johansson B; Mellstedt H; Nilsson B; Ost A
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):747-55. PubMed ID: 6683648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.